Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Complement factor D (Homo sapiens (Human)) | BDBM335516![]() ((3-acetyl-1-(2-((2S,4R)- 2-(3-chloro-2- fluorobenz...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335550![]() ((2S,4R)-1-(2-(3-acetyl-5-(5- methylpyrimidin-2-ylo...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335539![]() (1-(2-((2S,4R)-2-(2'-chloro- 2-fluorobiphenyl-3- yl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335540![]() ((2S,4R)-1-(2-(3-acetyl-6- (pyrimidin-2-yloxy)-1H- ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335542![]() ((2S,4R)-1-(2-(3-acetyl-6- (pyrimidin-2-yloxy)-1H- ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335549![]() ((2S,4R)-1-(2-(3-acetyl-5- (pyrimidin-2-yloxy)-1H- ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335523![]() ((((3-acetyl-1-(2-((2S,4R)- 2-(3-chloro-2- fluorobe...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335530![]() (3-(hexadecyloxy)propyl hydrogen (3-acetyl-1-(2- ((...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335534![]() ((2S,2'S)-isopropyl 2,2'- (((3-acetyl-1-(2-((2S,4R)...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335553![]() ((2S,4R)-1-(2-(3-acetyl-5-(2- chloropyrimidin-5-ylo...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335515![]() (US10550140, Compound 7 | US9732104, Compound 7 | d...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335520![]() (US10550140, Compound 10 | US9732104, Compound 10 |...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335522![]() ((((3-acetyl-1-(2- ((2S,4R)-2-(3-chloro-2- fluorobe...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335528![]() (US10550140, Compound 18 | US9732104, Compound 18 |...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335533![]() (1,1'-(((3-acetyl-1-(2- ((2S,4R)-2-(3-chloro-2- flu...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335510![]() ((1R,3S,5R)-2-(2-(3-acetyl-6- (cyclopropylmethoxy)-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335521![]() ((3-acetyl-1-(2-((2S,4R)- 2-(3-chloro-2- fluorobenz...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335535![]() ((3-acetyl-1-(2-((2S,4R)-4- fluoro-2-(3-fluoro-4- (...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335541![]() (1-(2-((2S,4R)-2-(2'-chloro- 2-fluorobiphenyl-3- yl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335546![]() ((2S,4R)-1-(2-(3-acetyl-5-(2- cyanopyrimidin-5-ylox...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335547![]() ((2S,4R)-1-(2-(3-acetyl-5-(5- fluoropyrimidin-2-ylo...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335548![]() ((2S,4R)-1-(2-(3-acetyl-5- (pyrimidin-2-yloxy)-1H- ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335552![]() ((2S,4R)-1-(2-(3-acetyl-5-(5- (trifluoromethyl)pyri...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335509![]() (3-acetyl-1-(2-((2S,4R)-2-(3- chloro-2- fluorobenzy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335517![]() (3-acetyl-1-(2-((2S,4R)-2- (3-chloro-2- fluorobenzy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335512![]() ((2S,4R)-1-(2-(3-acetyl-6- (cyclopropylmethoxy)-1H-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335513![]() ((2S,4R)-1-(2-(3-acetyl-6-(2- cyclopropylethoxy)-1H...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335551![]() ((2S,4R)-1-(2-(3-acetyl-5-(5- methylpyrimidin-2-ylo...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335508![]() ((2S,4R)-1-(2-(3-acetyl-6- (cyclopropylmethoxy)- 1H...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335527![]() ((2S,4R)-1-(2-(3-acetyl-6- (sulfamoylmethoxy)- 1H-i...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335529![]() ((3-acetyl-1-(2-((2S,4R)- 2-((R)-1-(3-chloro-2- flu...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335537![]() ((3-acetyl-1-(2-((2S,4R)- 4-fluoro-2-(2-fluoro-3- (...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335538![]() (6-(N-tert- butylsulfamoylmethoxy)- 1-(2-((2S,4R)-2...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335544![]() ((1R,3S,5R)-2-(2-(3-acetyl-5- (5-bromopyrimidin-2-y...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335545![]() ((2S,4R)-1-(2-(3-acetyl-5-(5- bromopyrimidin-2-ylox...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335524![]() (US10550140, Compound 14 | US9732104, Compound 14 |...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335525![]() ((2S,4R)-1-(2-(3-acetyl-6-(N- tert-butylsulfamoylme...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335526![]() ((3-acetyl-1-(2-((2S,4R)-2- (3-chloro-2- fluorobenz...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335531![]() ((((3-acetyl-1-(2- ((2S,4R)-2-(3-chloro-2- fluorobe...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335532![]() ((3-acetyl-1-(2-((2S,4R)- 2-((3-chloro-2-fluoro- ph...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335536![]() ((3-acetyl-1-(2-((2S,4R)-4- fluoro-2-(3-phenoxy- ph...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335543![]() ((2S,4R)-1-(2-(3-acetyl-5-(5- bromopyrimidin-2-ylox...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM335514![]() ((2S,4R)-1-(2-(3-acetyl-6- ((tricyclo[8.2.2.24,7]he...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Achillion Pharmaceuticals Inc US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9732104 (2017) BindingDB Entry DOI: 10.7270/Q24X59WF | |||||||||||
More data for this Ligand-Target Pair |